Health Tech Stocks
Recent market-moving SEC filings and news across health tech companies, ranked by Wiseek's 1–10 importance score.
How Wiseek curates this list
Every item here is a high-importance (score ≥ 7) SEC filing or licensed news event for a health tech company, sourced from SEC EDGAR and licensed news wires and ranked by Wiseek's 1–10 importance score. The underlying source is linked from each article. See our methodology and editorial policy.
Related Healthcare industries
Biotech StocksMedical Device StocksPharmaceutical StocksDiagnostics & Research StocksMedical Instrument StocksHealthcare Facility Stocks
See the full Healthcare sector feed.
Mangoceuticals and Nuclea Energy Mutually Terminate Reverse Merger Agreement
Simulations Plus Discloses Merger Litigation and Supplemental Valuation Details Ahead of Aug 27 Vote
Veeva Names Dan Rizzo EVP of Sales as President Schwenger Departs for CEO Role
BullFrog AI Secures 180-Day Nasdaq Extension and Readies Reverse Split to Regain Compliance
Prospectus Supplement Reveals Terms of New $25M Equity Line and $1M Insider Purchase
Prospectus Supplement Reveals $25M Equity Line and Nasdaq Delisting Notice
Crosslink Capital Commits to Vote for Weave's $7.40/Share Merger
OneMedNet Sets September 18 Vote on Reverse Split and Equity Plan Expansion
Merck-Moderna Phase 3 Win Validates Tempus AI's Personalis Bet, Stock Jumps 18%
CareCloud Confirms 3.7M Patient Records Stolen in Data Breach
Weave-Fransisco Partners Deal Carries $39M Termination Fee
Weave Communications Files Full Merger Agreement with Francisco Partners: $7.40/Share Cash Deal, Termination Fees, and 14.5% Voting Support
GE HealthCare Names William Grogan as Permanent CFO, Succeeding Interim
Weave Communications to Be Acquired by Francisco Partners for $7.40/Share in Cash
Francisco Partners to Acquire Weave for $7.40/Share in $650M Deal
CFO Gregory Gould Buys $24,500 of Aclarion Stock at $2.45
Talkspace Completes $870.6M Acquisition by Universal Health Services
Director Ryan Bond Buys $50K of Aclarion Stock at $2.37
HeartBeam Launches $25M At-The-Market Offering Amid Going Concern Warning
MSP Recovery Secures $0.21M in Emergency Advances as Liquidity Crisis Deepens
MSP Recovery Secures $0.21M in Emergency Advances Amid Critical Liquidity Crisis
MSP Recovery Secures $0.21M in Emergency Advances, Warns No Further Funding Available
MSP Recovery Secures $0.21M in Emergency Advances as Liquidity Crisis Deepens
MSP Recovery Secures $235K in Emergency Advances from Hazel and VRM
HeartBeam Launches $25M At-The-Market Offering Amid Going Concern
Heartflow Affiliate Arthur Cohen Files to Sell 200,000 Shares (~$8.4M)
OneMedNet 10-Q Reveals New $25M Equity Line Terms and $1M Insider Purchase
BullFrog AI Flags Going Concern Doubt and Nasdaq Bid Price Deficiency
VASO Corp Q2 2026: Net Income $544K, NetWolves Sale Finalized
HeartFlow Beats Q2 EPS by 6 Cents, Raises Guidance; Stock Surges 36% to 52-Week High
Heartflow Affiliate Files to Sell $6.2M in Shares
SCWorx Q2 Loss Narrows to $121K; Nasdaq Compliance in Progress
Vaso Swings to Q2 Profit as Revenue Climbs 8.3% to $11.2M
Owlet's Q2 10-Q Flags Unremediated Material Weaknesses and Restated Financials
Mangoceuticals Q2 2026: Cash Drops to $229K, Going Concern Warning Reiterated, Nuclea Reverse Merger Details Emerge
HSR Waiting Period Expires for Altaris' $375M Acquisition of Simulations Plus
Healthcare Triangle's Q2 revenue jumps 158% to $9.2M, but losses widen and cash dwindles to $1.9M
Strome Entities Dump 1.39M HeartBeam Shares at Steep Losses
Heartflow Q2 10-Q: 48% Revenue Growth, $7.5M Impairment, and New Insider Trading Plans
Nuclea Energy to Acquire Moltex's Advanced Nuclear Tech Assets in Cash Deal